NEW

ReadySet Surgical Launches RS Capture to help Hospitals Eliminate Billing Discrepancies for Implantable Medical Devices

New application delivers guaranteed savings through automated “bill-only” charge reconciliation, streamlining implant supply chain management ReadySet Surgical today announced the launch of RS Capture, enhancing the Company’s cloud-based, end-to-end platform to...

Webinar Addresses Reusable Medical Devices

The OR Today Webinar Series continues to deliver valuable insights. “Getting the Most Out of Your Reusable Medical Devices” presented by Kevin Anderson, BSN, RN, CNOR, CSSM, CRCST, CHL, CIS, CER, was a hit with attendees. It was also eligible for one (1) continuing...

Ultrapotent compound may help treat C. diff, reduce recurrence

Clostridioides difficile, or C. diff, is the leading cause of health care-associated infection in the U.S. Only two antibiotics, vancomycin and fidaxomicin, are FDA-approved for the treatment of C. diff, but even these therapies suffer from high treatment failure and...

Tampa General Hospital, Philips announce partnership

The seven-year agreement will upgrade technology throughout the hospital and improve efficiency Tampa General Hospital (TGH) and Royal Philips announced they are creating a long-term strategic partnership designed to keep Tampa General Hospital at the forefront of...

FDA takes action to increase U.S. supplies through instructions for PPE and device manufacturers

Today, the U.S. Food and Drug Administration took action to increase U.S. supplies to support the U.S. response to COVID-19 by providing instructions to manufacturers importing personal protective equipment and other devices.

One of FDA’s priorities in combating the COVID-19 pandemic is facilitating access to critical personal protective equipment (PPE) and devices. We are engaging with importers and others involved in the import trade community during this pandemic to facilitate the entry of needed products, including PPE, into the U.S. These instructions to importers clarify the types of PPE that can be imported without engaging with FDA. They also include information about the type of information importers can submit to facilitate their entries. We have adjusted our import screening to further expedite imports of legitimate products and are continually monitoring our import systems to prevent and mitigate any potential issues.

The FDA established a special email inbox, COVID19FDAIMPORTINQUIRIES@fda.hhs.gov, for industry representatives to quickly communicate with the agency and address questions or concerns.

The agency is providing maximum flexibility to those seeking to bring PPE into the U.S. and are ready and available to engage with importers to minimize disruptions during the importing process.

Many companies are stepping up across America to help with manufacturing critical and life-saving medical supplies to strengthen the U.S. response. To support their efforts, we are setting up additional avenues of communication to FDA so they can contact us with any questions or concerns around the clock.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X